<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62270">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02295267</url>
  </required_header>
  <id_info>
    <org_study_id>2012-0519</org_study_id>
    <nct_id>NCT02295267</nct_id>
  </id_info>
  <brief_title>Molecular Analysis of IgE Antibodies in Walnut Allergic Patients</brief_title>
  <official_title>Molecular Analysis of IgE Antibodies in Walnut Allergic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Paul Ehrlich Institute Langen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Marien Hospital Bonn</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Thermo Fisher Scientific</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Accurate diagnosis of food allergy depends on the identification of the causative allergenic
      molecule(s). The proposed study intends to investigate and compare the pattern of IgE
      antibody sensitisation in walnut allergic subjects from three different regions of Europe
      (south (SEU) and central/north (C/NEU), to evaluate the diagnostic utility of a panel of
      novel allergen reagents.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Accurate diagnosis of food allergy depends on the identification of the causative allergenic
      molecule(s). Thus, full characterization of the major allergens of walnut and their clinical
      importance is an important undertaking.

      The proposed study intends to investigate and compare the pattern of IgE antibody
      sensitisation in walnut allergic subjects from three different regions of Europe (south
      (SEU) and central/north (C/NEU), to evaluate the diagnostic utility of a panel of novel
      allergen reagents.

      With a view towards improved in vitro diagnostic methods, we intend to evaluate the
      diagnostic potential of recombinant walnut allergens in patients with walnut allergy
      confirmed by a positive provocation or supported by a convincing history of anaphylactic
      reaction(s) to walnut in the past, patients with pollinosis but no symptoms of walnut
      allergy and non-atopic control subjects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>numbers of patients with walnut allergy</measure>
    <time_frame>December 2012 to November 2017, up to 5 years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Food Allergy</condition>
  <arm_group>
    <arm_group_label>walnut allergy provocation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>inclusion of walnut allergic patients, food provocation with walnut</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>walnut allergy provocation</intervention_name>
    <description>double blind placebo controlled food challenge</description>
    <arm_group_label>walnut allergy provocation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent

          -  Group A: positive case history of allergic reaction(s) to walnut

          -  Group B: positive case history of allergy to birch, grass or olive pollen and no case
             history of allergic reaction(s) to walnut

          -  Group C: no case history of atopic disease

        Exclusion Criteria:

          -  Known pregnancy

          -  Breast-feeding of infant

          -  Treatment with the following drugs (or shortest interval between last treatment and
             food challenge or SPT):

          -  corticosteroids (2 weeks): applied systemically, to the nose or locally on the skin
             test area.

          -  antihistamines (3 days) except hydroxyzine (10 days)

          -  betablocker agents (1 day)

          -  angiotensin converting enzyme inhibitors (2 days)

          -  Any major organic or infectious disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Ballmer-Weber, PI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Allergy Unit, Department of Dermatology, University Zürich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara Ballmer-Weber, PI</last_name>
    <phone>+41 2553976</phone>
    <email>barbara.ballmer@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Allergy Unit, Department of Dermatology, University Hospital</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Ballmer-Weber, Prof, MD</last_name>
      <phone>+41442553976</phone>
      <email>barbara.ballmer@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Barbara Ballmer-Weber, Prof, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 26, 2016</lastchanged_date>
  <firstreceived_date>November 11, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Food allergy</keyword>
  <keyword>Walnut</keyword>
  <keyword>Components</keyword>
  <keyword>Allergens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Food Hypersensitivity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Antibodies</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
